Melvin D'Souza outlines the strategy that Novo Nordisk Saudi Arabia – the country’s market leader in diabetes care, obesity, hemophilia, and growth hormone treatment – is following and analyzes the potential impact of local content enhancement for the Kingdom’s Vision 2030 healthcare transformation plans.
The fact that Novo Nordisk in Saudi Arabia has been ranked as the No.1 ‘Best Places to Work’ for the last three years and ranked No.1 in the Best Places to Work for women for the last two years, across a cross-section of industries, is a good acknowledgement of our efforts
